Skip to main content
Premium Trial:

Request an Annual Quote

Battelle to Test IntelligentMDx's Assay for BK Virus

NEW YORK (GenomeWeb News) – The non-profit Battelle Eastern Science and Technology Center will conduct performance verification studies of IntelligentMDx’s molecular diagnostic assays, the company said today.
Battelle, which is headquartered in Columbus, Ohio, will perform various tests of the company’s Quantitative BK Virus Real-Time PCR Assay to identify its performance characteristics.
BKV is an important pathogen involved in nephrophathy in kidney transplant patients and hemorrhagic cystitis in stem cell transplant patients. The IntelligentMDx test has been developed to track the course of infection and to monitor the response to treatment.
Financial terms of the agreement were not released.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.